Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Nippon Chemiphar Is Managing To Slow Its Decline
As Company Credits Structural Reforms For Generating Operating Income
Feb 23 2021
•
By
Akriti Seth
Nippon Chemiphar’s rate of YoY decline falls from 7.5% to 3% • Source: Shutterstock
More from Generics
More from Products